Drug intelligence / Profile preview

O-(2-[18F]fluoroethyl)-L-tyrosine

Development stage
Phase 2
Lead developer
Curium
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

O-(2-[18F]fluoroethyl)-L-Tyrosine, commonly known as 18F-FET, is a radiolabeled synthetic amino acid used as a positron emission tomography (PET) imaging tracer. Labeled with the radioactive isotope fluorine‑18, it is primarily utilized in neuro-oncology for diagnosing, treatment planning, and monitoring of brain tumors such as gliomas. The compound is actively transported into tumor cells via the L-type amino acid transporter system but is not incorporated into proteins or readily degraded. This results in high intracellular concentrations within tumor cells and enables detailed metabolic imaging of tumors. Compared to standard PET tracers like 18F-fluorodeoxyglucose (FDG), which can be less sensitive for brain tumors due to high background uptake in normal brain tissue, 18F-FET offers improved specificity for detecting malignant lesions and distinguishing them from inflammatory tissue[1][2][10]. It has also shown selective uptake in squamous cell carcinomas outside the central nervous system[6]. The agent's favorable pharmacokinetics and stability make it suitable for clinical use in PET imaging.

Brand names
Pixclara
Other names
O-(2-fluoroethyl)-L-tyrosine F-18178433-03-91326R5J1IAl-(18F)FETO-(2-Fluorethyl)-l-thyrosine
02

Targets

SLC7A5 (Large neutral amino acid transporter small subunit 1)

Beyond the preview

Go deeper on O-(2-[18F]fluoroethyl)-L-tyrosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on O-(2-[18F]fluoroethyl)-L-tyrosine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call